Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Shandong Sanyuan Biotechnology Co Ltd
Additional Paid In Capital
Shandong Sanyuan Biotechnology Co Ltd
Additional Paid In Capital Peer Comparison
600887
603288
300999
002714
300498
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
|
Additional Paid In Capital
¥3.5B
|
CAGR 3-Years
265%
|
CAGR 5-Years
146%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Additional Paid In Capital
¥13.4B
|
CAGR 3-Years
95%
|
CAGR 5-Years
36%
|
CAGR 10-Years
6%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Additional Paid In Capital
¥142.5m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-27%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Additional Paid In Capital
¥36.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Additional Paid In Capital
¥17.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
43%
|
CAGR 10-Years
37%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Additional Paid In Capital
¥9.8B
|
CAGR 3-Years
24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Sanyuan Biotechnology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
3.5B
CNY
Based on the financial report for Dec 31, 2023, Shandong Sanyuan Biotechnology Co Ltd's Additional Paid In Capital amounts to 3.5B CNY.
What is Shandong Sanyuan Biotechnology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
146%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Shandong Sanyuan Biotechnology Co Ltd have been 265% over the past three years , 146% over the past five years .
You don't have any saved screeners yet
